Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort

Abstract Background Metabolic syndrome (MetS) has been proposed as a clinically identifiable high-risk state for the prediction and prevention of cardiovascular diseases and type 2 diabetes mellitus. As a promising “omics” technology, metabolomics provides an innovative strategy to gain a deeper und...

Full description

Bibliographic Details
Main Authors: Hao Wang, Youxin Wang, Xingang Li, Xuan Deng, Yuanyuan Kong, Wei Wang, Yong Zhou
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-022-01716-0
_version_ 1828087253125038080
author Hao Wang
Youxin Wang
Xingang Li
Xuan Deng
Yuanyuan Kong
Wei Wang
Yong Zhou
author_facet Hao Wang
Youxin Wang
Xingang Li
Xuan Deng
Yuanyuan Kong
Wei Wang
Yong Zhou
author_sort Hao Wang
collection DOAJ
description Abstract Background Metabolic syndrome (MetS) has been proposed as a clinically identifiable high-risk state for the prediction and prevention of cardiovascular diseases and type 2 diabetes mellitus. As a promising “omics” technology, metabolomics provides an innovative strategy to gain a deeper understanding of the pathophysiology of MetS. The study aimed to systematically investigate the metabolic alterations in MetS and identify biomarker panels for the identification of MetS using machine learning methods. Methods Nuclear magnetic resonance-based untargeted metabolomics analysis was performed on 1011 plasma samples (205 MetS patients and 806 healthy controls). Univariate and multivariate analyses were applied to identify metabolic biomarkers for MetS. Metabolic pathway enrichment analysis was performed to reveal the disturbed metabolic pathways related to MetS. Four machine learning algorithms, including support vector machine (SVM), random forest (RF), k-nearest neighbor (KNN), and logistic regression were used to build diagnostic models for MetS. Results Thirteen significantly differential metabolites were identified and pathway enrichment revealed that arginine, proline, and glutathione metabolism are disturbed metabolic pathways related to MetS. The protein-metabolite-disease interaction network identified 38 proteins and 23 diseases are associated with 10 MetS-related metabolites. The areas under the receiver operating characteristic curve of the SVM, RF, KNN, and logistic regression models based on metabolic biomarkers were 0.887, 0.993, 0.914, and 0.755, respectively. Conclusions The plasma metabolome provides a promising resource of biomarkers for the predictive diagnosis and targeted prevention of MetS. Alterations in amino acid metabolism play significant roles in the pathophysiology of MetS. The biomarker panels and metabolic pathways could be used as preventive targets in dealing with cardiometabolic diseases related to MetS.
first_indexed 2024-04-11T05:09:29Z
format Article
id doaj.art-3becbe30d9264fb4a47db1734f741e74
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-04-11T05:09:29Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-3becbe30d9264fb4a47db1734f741e742022-12-25T12:04:29ZengBMCCardiovascular Diabetology1475-28402022-12-0121111210.1186/s12933-022-01716-0Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health CohortHao Wang0Youxin Wang1Xingang Li2Xuan Deng3Yuanyuan Kong4Wei Wang5Yong Zhou6Department of Clinical Epidemiology and Evidence-Based Medicine, Beijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical UniversityBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical UniversityCenter for Precision Medicine, School of Medical and Health Sciences, Edith Cowan UniversityClinical Research Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Clinical Epidemiology and Evidence-Based Medicine, Beijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical UniversityBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical UniversityClinical Research Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineAbstract Background Metabolic syndrome (MetS) has been proposed as a clinically identifiable high-risk state for the prediction and prevention of cardiovascular diseases and type 2 diabetes mellitus. As a promising “omics” technology, metabolomics provides an innovative strategy to gain a deeper understanding of the pathophysiology of MetS. The study aimed to systematically investigate the metabolic alterations in MetS and identify biomarker panels for the identification of MetS using machine learning methods. Methods Nuclear magnetic resonance-based untargeted metabolomics analysis was performed on 1011 plasma samples (205 MetS patients and 806 healthy controls). Univariate and multivariate analyses were applied to identify metabolic biomarkers for MetS. Metabolic pathway enrichment analysis was performed to reveal the disturbed metabolic pathways related to MetS. Four machine learning algorithms, including support vector machine (SVM), random forest (RF), k-nearest neighbor (KNN), and logistic regression were used to build diagnostic models for MetS. Results Thirteen significantly differential metabolites were identified and pathway enrichment revealed that arginine, proline, and glutathione metabolism are disturbed metabolic pathways related to MetS. The protein-metabolite-disease interaction network identified 38 proteins and 23 diseases are associated with 10 MetS-related metabolites. The areas under the receiver operating characteristic curve of the SVM, RF, KNN, and logistic regression models based on metabolic biomarkers were 0.887, 0.993, 0.914, and 0.755, respectively. Conclusions The plasma metabolome provides a promising resource of biomarkers for the predictive diagnosis and targeted prevention of MetS. Alterations in amino acid metabolism play significant roles in the pathophysiology of MetS. The biomarker panels and metabolic pathways could be used as preventive targets in dealing with cardiometabolic diseases related to MetS.https://doi.org/10.1186/s12933-022-01716-0Metabolic syndromeMachine learningMetabolomicsBiomarkersDiagnostic modelsAmino acid metabolism
spellingShingle Hao Wang
Youxin Wang
Xingang Li
Xuan Deng
Yuanyuan Kong
Wei Wang
Yong Zhou
Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort
Cardiovascular Diabetology
Metabolic syndrome
Machine learning
Metabolomics
Biomarkers
Diagnostic models
Amino acid metabolism
title Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort
title_full Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort
title_fullStr Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort
title_full_unstemmed Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort
title_short Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort
title_sort machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome findings from the china suboptimal health cohort
topic Metabolic syndrome
Machine learning
Metabolomics
Biomarkers
Diagnostic models
Amino acid metabolism
url https://doi.org/10.1186/s12933-022-01716-0
work_keys_str_mv AT haowang machinelearningofplasmametabolomeidentifiesbiomarkerpanelsformetabolicsyndromefindingsfromthechinasuboptimalhealthcohort
AT youxinwang machinelearningofplasmametabolomeidentifiesbiomarkerpanelsformetabolicsyndromefindingsfromthechinasuboptimalhealthcohort
AT xingangli machinelearningofplasmametabolomeidentifiesbiomarkerpanelsformetabolicsyndromefindingsfromthechinasuboptimalhealthcohort
AT xuandeng machinelearningofplasmametabolomeidentifiesbiomarkerpanelsformetabolicsyndromefindingsfromthechinasuboptimalhealthcohort
AT yuanyuankong machinelearningofplasmametabolomeidentifiesbiomarkerpanelsformetabolicsyndromefindingsfromthechinasuboptimalhealthcohort
AT weiwang machinelearningofplasmametabolomeidentifiesbiomarkerpanelsformetabolicsyndromefindingsfromthechinasuboptimalhealthcohort
AT yongzhou machinelearningofplasmametabolomeidentifiesbiomarkerpanelsformetabolicsyndromefindingsfromthechinasuboptimalhealthcohort